<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240914063038N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-09-26</date_registration>
      <primary_sponsor>University of Lahore</primary_sponsor>
      <public_title>Electrical Stimulation in addition to motor Re-learning Programme on Spasticity and Upper limb Function in Stroke Patients</public_title>
      <acronym></acronym>
      <scientific_title>Electrical Stimulation in addition to motor Re-learning Programme on Spasticity and Upper limb Function in Stroke Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-03-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>62</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/79084</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization will be used by one of the research team members who will be blinded to study and will not be involved in patient recruitment. Participants will be randomly allocated into two groups through lottery method, Blinding description: This study is a single blinded study in which outcome assessor will be unaware of the treatment group.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Stroke is a neurological disorder characterized by blockage of blood vessels. Clots form in the brain and interrupt blood flow, clogging arteries and causing blood vessels to break, leading to bleeding. Rupture of the arteries leading to the brain during stroke results in the sudden death of brain cells owing to a lack of oxygen..</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group : Group A will be  received electrical stimulation for 15 minutes with hot pack and the stretching of muscles will be performed at the end. The sessions will be  last 60 minutes five days a week for an 8-week period. The parameter of the stimulation (Comfystim®) will be included a frequency of 35HZ,Synced option of EMS, pulse width of 250µ, Asymmetrical biphasic waveform, duty cycle of 5 secs on and 5secs off, and the amplitude was adjusted to the maximal tolerance of patient .To stimulate wrist flexion, active electrode was placed over the flexor carpi radials and the indifferent electrode over the flexor carpi ulnaris. To stimulate Elbow flexion, active electrode over the biceps and the indifferent electrode over the brachialis. To stimulate wrist and finger extension the active electrode will be positioned over extensor digitorum communis (EDC) and the indifferent electrode over extensor pollicis longus (EPL) and abductor pollicis longus (AbPL). To stimulate extension of the arm, active electrode will be placed over the anterior deltoid and the indifferent electrode over the triceps.The participants randomly will be allocated in Group A received the Motor Re-learning Programme with electrical stimulation.  Motor re-learning programme which included different types of task specific exercises (3 reps &amp; 10 times) will be  performed. This motor re-learning programme includes following steps as treatment plans : Step 1: Analysis of Task Step 2: Practice of missing component Step 3: Practice of Task Step 4: Transference of training. Intervention 2: Intervention group B: In Group B Electrical stimulation without motor re-learning programme will be  given for 60 mins on the upper limb for five days per week for a period of 8th weeks. First 15 minutes’ hot pack with electrical stimulation will be applied. The stimulation parameters and electrode placements will be the same as those previously mentioned. And upper limb Stretches of long finger flexors, Wrist flexors, Thumb adductors, Forearm pronators, Adductors and Internal rotators of GH joint were performed. Home Based Programme: This protocol will be  including different exercises like Wrist flexion and extension, Finger flexion and extension, Forearm supination and pronation, tapping table top with all fingers, Opening of all fingers and Counting with fingers.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic data and data related to final outcome will be shared by maintaining the confidentially

When:
Data will be available after the publication after the publication of findings till six months

To whom:
Nimra Zulfaqar

Conditions:
For research purpose

Where to obtain:
To the correspomding author of the stuyd , Nimra Zulfaqar and can contact on +92324569208 nimrazulfqar4569@gmail.com

How to obtain:
Open access and thee is the traditional public data release where anyone can get access to the data

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nimra Zulfaqar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Lahore Teaching Hospital Lahore , Punjab , Pakistan</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>55150</zip>
        <telephone>+92 324 4569208</telephone>
        <email>nimrazulfqar4569@gmail.com</email>
        <affiliation>University of Lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nimra Zulfaqar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Lahore Teaching Hospital Lahore , Punjab , Pakistan</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>55150</zip>
        <telephone>+92 324 4569208</telephone>
        <email>nimrazulfqar4569@gmail.com</email>
        <affiliation>University of Lahore</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Aged between 25-65 years
Both Male and females
Stroke Onset ≥3 months
Ischemia Stroke
Patients with limb spasticity equal to 2 or less than 2 on modified Ashworth scale
Patients with English reading and writing skills</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with visual and auditory defects
Patients with severe shoulder or wrist pain
Patients with upper limb fractures/dislocations
Contraindication to Electrical stimulation such as skin allergy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I63.30</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral infarction due to thrombosis of unspecified cerebral artery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group : Group A will be  received electrical stimulation for 15 minutes with hot pack and the stretching of muscles will be performed at the end. The sessions will be  last 60 minutes five days a week for an 8-week period. The parameter of the stimulation (Comfystim®) will be included a frequency of 35HZ,Synced option of EMS, pulse width of 250µ, Asymmetrical biphasic waveform, duty cycle of 5 secs on and 5secs off, and the amplitude was adjusted to the maximal tolerance of patient .To stimulate wrist flexion, active electrode was placed over the flexor carpi radials and the indifferent electrode over the flexor carpi ulnaris. To stimulate Elbow flexion, active electrode over the biceps and the indifferent electrode over the brachialis. To stimulate wrist and finger extension the active electrode will be positioned over extensor digitorum communis (EDC) and the indifferent electrode over extensor pollicis longus (EPL) and abductor pollicis longus (AbPL). To stimulate extension of the arm, active electrode will be placed over the anterior deltoid and the indifferent electrode over the triceps.The participants randomly will be allocated in Group A received the Motor Re-learning Programme with electrical stimulation.  Motor re-learning programme which included different types of task specific exercises (3 reps &amp; 10 times) will be  performed. This motor re-learning programme includes following steps as treatment plans : Step 1: Analysis of Task Step 2: Practice of missing component Step 3: Practice of Task Step 4: Transference of training</i_keyword>
      <i_keyword>Intervention group B: In Group B Electrical stimulation without motor re-learning programme will be  given for 60 mins on the upper limb for five days per week for a period of 8th weeks. First 15 minutes’ hot pack with electrical stimulation will be applied. The stimulation parameters and electrode placements will be the same as those previously mentioned. And upper limb Stretches of long finger flexors, Wrist flexors, Thumb adductors, Forearm pronators, Adductors and Internal rotators of GH joint were performed. Home Based Programme: This protocol will be  including different exercises like Wrist flexion and extension, Finger flexion and extension, Forearm supination and pronation, tapping table top with all fingers, Opening of all fingers and Counting with fingers</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The Modified Ashworth Scale is a clinical assessment tool used to measure the spasticity of muscles in individuals with neurological conditions, such as cerebral palsy, stroke, multiple sclerosis, or spinal cord injuries. Timepoint: 8th weeks. Method of measurement: The Modified Ashworth Scale typically uses a 6-point grading system to assess muscle tone.The csale ranges from 0 to 4 with an additional grade of 1+. Where 0 means normal and 4 severe spasticity.</prim_outcome>
      <prim_outcome>The Motor evaluation scale for upper extremity in stroke (MESUPES) measures quality of movement performance of the hemiparetic arm and hand in stroke patients. MESUPES is comprised of 17 items in two subscales: MESUPES–Arm function: 8 items with 6 response categories (0-5) and other one is MESUPES–Hand function: 9 items with 3 response categories (0-2). Timepoint: 8th weeks. Method of measurement: The maximum achievable score is 58 (MESUPES-Arm maximum score is 40; MESUPES-Hand maximum score is 18). The patient is awarded one score for each task, and the highest score is retained. A score of 0 is awarded when the patient demonstrated inadequate tone, abnormal muscle contractions, synergic (flexor/extensor) or mass movement patterns.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The National Institutes of Health Stroke Scale (NIHSS) is a widely used clinical tool for assessing the severity of stroke-related neurological deficits. It was developed by the National Institute of Neurological Disorders and Stroke (NINDS) and is utilized to evaluate the status of patients who have experienced a stroke or other cerebrovascular events. Timepoint: 8th weeks. Method of measurement: The NIHSS consists of a series of 11 neurological examination items, and each item assesses specific functions related to different areas of the brain. Each item is scored on a scale from 0 to 3 or 0 to 4, depending on the specific item. A higher score indicates a more severe neurological deficit. The scores from each item are then added together to give a total NIHSS score, which can range from 0 (no stroke-related deficits) to 42 (maximum severity). (Zöllner et al., 2020).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>None</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-02-15</approval_date>
        <contact_name>Research Ethics Committee of University of Lahore</contact_name>
        <contact_address>University of Lahore Teaching Hospital Lahore , Punjab , Pakistan Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
